Valeo Financial Advisors, LLC Chimerix Inc Transaction History
Valeo Financial Advisors, LLC
- $3.97 Billion
- Q4 2024
A detailed history of Valeo Financial Advisors, LLC transactions in Chimerix Inc stock. As of the latest transaction made, Valeo Financial Advisors, LLC holds 146,186 shares of CMRX stock, worth $640,294. This represents 0.01% of its overall portfolio holdings.
Number of Shares
146,186
Previous 81,766
78.79%
Holding current value
$640,294
Previous $76,000
568.42%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CMRX
# of Institutions
75Shares Held
36.7MCall Options Held
182KPut Options Held
108K-
Ra Capital Management, L.P. Boston, MA8.8MShares$38.5 Million0.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.04MShares$17.7 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.77MShares$16.5 Million0.32% of portfolio
-
Monaco Asset Management Sam2.82MShares$12.4 Million1.45% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.56MShares$11.2 Million0.0% of portfolio
About CHIMERIX INC
- Ticker CMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,622,896
- Market Cap $384M
- Description
- Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...